Literature DB >> 26600274

Critical Care at the End of Life.

Kathleen M Akgün1, Jennifer M Kapo2, Mark D Siegel3.   

Abstract

Intensive care unit (ICU) admission is common among patients approaching the end of their lives from acute as well as chronic life-limiting conditions. ICU providers are expected to have basic palliative care skills integrated into their routine practice. Palliative care skills can be applied to all ICU patients, regardless of prognosis, and may improve patient- and family-centered end of life (EOL) care in the ICU. Consultative palliative care models may be required for more complex palliative care needs including symptom management, medical decision making, and bereavement. This review discusses integrative and consultative palliative care models and the role of triggers for palliative care consultation, particularly when they are tailored to the needs of individual ICUs. We then review the evidence for providing several palliative care domains in the ICU and some of the ethical considerations surrounding EOL care in the ICU. Finally, we highlight the importance of self-care and peer support groups to mitigate the risk of burnout for clinicians providing EOL care in the ICU. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2015        PMID: 26600274     DOI: 10.1055/s-0035-1565254

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  2 in total

1.  Trend of Decreased Length of Stay in the Intensive Care Unit (ICU) and in the Hospital with Palliative Care Integration into the ICU.

Authors:  Eluned Mun; Clementina Ceria-Ulep; Lillian Umbarger; Craig Nakatsuka
Journal:  Perm J       Date:  2016-08-31

2.  Communication strategies to mitigate fear and suffering among COVID-19 patients isolated in the ICU and their families.

Authors:  Kathleen M Akgün; Tracy L Shamas; Shelli L Feder; Dena Schulman-Green
Journal:  Heart Lung       Date:  2020-05-03       Impact factor: 2.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.